These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 36182068)
21. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Chen D; Liu X; Lu X; Tian J Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010 [TBL] [Abstract][Full Text] [Related]
22. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents. Zhao J; Feng SS Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357 [TBL] [Abstract][Full Text] [Related]
24. Nanocarriers for Anticancer Drug Targeting: Recent Trends and Challenges. Dahiya S; Dahiya R; Hernández E Crit Rev Ther Drug Carrier Syst; 2021; 38(6):49-103. PubMed ID: 34587429 [TBL] [Abstract][Full Text] [Related]
25. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488 [TBL] [Abstract][Full Text] [Related]
26. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy. Aigner A; Fischer D Pharmazie; 2016 Jan; 71(1):27-34. PubMed ID: 26867350 [TBL] [Abstract][Full Text] [Related]
27. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. Varshosaz J; Farzan M World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089 [TBL] [Abstract][Full Text] [Related]
28. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles. Sivakumar P; Kim S; Kang HC; Shim MS Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426 [TBL] [Abstract][Full Text] [Related]
29. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model. Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488 [TBL] [Abstract][Full Text] [Related]
30. Research progress on siRNA delivery with nonviral carriers. Gao Y; Liu XL; Li XR Int J Nanomedicine; 2011; 6():1017-25. PubMed ID: 21720513 [TBL] [Abstract][Full Text] [Related]
31. siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer. Halbur C; Choudhury N; Chen M; Kim JH; Chung EJ SLAS Technol; 2019 Apr; 24(2):137-150. PubMed ID: 30616494 [TBL] [Abstract][Full Text] [Related]
32. Drug and gene co-delivery systems for cancer treatment. Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938 [TBL] [Abstract][Full Text] [Related]
33. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer. Ebrahimnejad P; Sodagar Taleghani A; Asare-Addo K; Nokhodchi A Drug Discov Today; 2022 Feb; 27(2):471-489. PubMed ID: 34781032 [TBL] [Abstract][Full Text] [Related]
34. Threatening cancer with nanoparticle aided combination oncotherapy. Rawal S; Patel MM J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445 [TBL] [Abstract][Full Text] [Related]
36. Targeted Liposomes for siRNA Delivery to Cancer. Eloy JO; Petrilli R; Raspantini GL; Lee RJ Curr Pharm Des; 2018; 24(23):2664-2672. PubMed ID: 30084323 [TBL] [Abstract][Full Text] [Related]
37. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Ashrafizadeh M; Delfi M; Hashemi F; Zabolian A; Saleki H; Bagherian M; Azami N; Farahani MV; Sharifzadeh SO; Hamzehlou S; Hushmandi K; Makvandi P; Zarrabi A; Hamblin MR; Varma RS Carbohydr Polym; 2021 May; 260():117809. PubMed ID: 33712155 [TBL] [Abstract][Full Text] [Related]
38. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy. Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948 [TBL] [Abstract][Full Text] [Related]
39. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells. Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C Nanoscale; 2021 Jul; 13(26):11414-11426. PubMed ID: 34160534 [TBL] [Abstract][Full Text] [Related]
40. Combinational drug delivery using nanocarriers for breast cancer treatments: A review. Olov N; Bagheri-Khoulenjani S; Mirzadeh H J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]